flash therapeutics

Yokohama, Japan Founded: 2019 • Age: 7 yrs
Novel therapeutics are developed to treat acute myeloid leukemia.

About flash therapeutics

flash therapeutics is a Healthcare company based in Yokohama (Japan) founded in 2019. Novel therapeutics are developed to treat acute myeloid leukemia. Its focus areas include Life Sciences, Oncology, Drugs and Bone Cancer.

Company details

Flash Therapeutics was founded in 2019 and is based in Yokohama, Japan. Operations center on the biotechnology sector, where novel therapeutics for acute myeloid leukemia are developed. These treatments target a key regulatory mechanism activated in refractory cases of the disease. Leukemic stem cells are selectively addressed to minimize relapse risks. The companys domain is flashthera.com, supporting research and development activities in oncology.

  • Headquarters Yokohama, Japan
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website flashthera.com
Operational Areas
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about flash therapeutics

flash therapeutics was founded in 2019.

flash therapeutics is headquartered in Yokohama, Japan. It is registered at Yokohama, Kanagawa, Japan.

Flash Therapeutics was founded in 2019 and is based in Yokohama, Japan. Operations center on the biotechnology sector, where novel therapeutics for acute myeloid leukemia are developed. These treatments target a key regulatory mechanism activated in refractory cases of the disease. Leukemic stem cells are selectively addressed to minimize relapse risks. The companys domain is flashthera.com, supporting research and development activities in oncology.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available